Safety Evaluation of Combined Ipratropium Bromide and Levosalbutamol Therapy in Patients with Lung Diseases: A Prospective and Cross-Sectional Observational Study
Journal of Young Pharmacists · 25.03.2026 · 18 (1) · 176-183
DOI: 10.5530/jyp.20260185 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Young Pharmacists, online erschienen am 25.03.2026. Verfasst von Rajesh Hadia und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hadia, R., Shah, A., Patel, J., Patel, R., Patel, V., & Rajput, H. S. (2026). Safety Evaluation of Combined Ipratropium Bromide and Levosalbutamol Therapy in Patients with Lung Diseases: A Prospective and Cross-Sectional Observational Study. Journal of Young Pharmacists, 18(1), 176-183. https://doi.org/10.5530/jyp.20260185
Vancouver
Hadia R, Shah A, Patel J, Patel R, Patel V, Rajput HS. Safety Evaluation of Combined Ipratropium Bromide and Levosalbutamol Therapy in Patients with Lung Diseases: A Prospective and Cross-Sectional Observational Study. Journal of Young Pharmacists. 2026;18(1):176-183. doi:10.5530/jyp.20260185
BibTeX
@article{Hadia2026,
author = {Hadia, Rajesh and Shah, Arti and Patel, Janvi and Patel, Riya and Patel, Vidhi and Rajput, Hemraj Singh},
title = {Safety Evaluation of Combined Ipratropium Bromide and Levosalbutamol Therapy in Patients with Lung Diseases: A Prospective and Cross-Sectional Observational Study},
journal = {Journal of Young Pharmacists},
year = {2026},
volume = {18},
number = {1},
pages = {176--183},
doi = {10.5530/jyp.20260185}
}
EUVIMED